ציפרוקסין 200
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
CIPROFLOXACIN AS LACTATE 0.2 G / 100 ML
Disponibbli minn:
BAYER ISRAEL LTD
Kodiċi ATC:
J01MA02
Għamla farmaċewtika:
SOLUTION FOR INFUSION
Rotta amministrattiva:
I.V
Manifatturat minn:
BAYER PHARMA AG, GERMANY
Grupp terapewtiku:
CIPROFLOXACIN
Indikazzjonijiet terapewtiċi:
Adults:Uncomplicated and complicated infections caused by ciprofloxacin sensitive pathogens.Children: For the treatment of acute pulmonary exacerbation of cystic fibrosis associated with Pseudomonas aeroginosa infections in pediatric patients aged 5-17 years.
Data ta 'l-awtorizzazzjoni:
2010-08-01
